Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab

Ellithi, Moataz; Shahid, Mahum; Abdullah, Hafez Mohammad; Bleeker, Jonathan

Ellithi, Moataz; Shahid, Mahum; Abdullah, Hafez Mohammad; Bleeker, Jonathan.

Ellithi, Moataz; University of South Dakota. Sanford School of Medicine. Sioux Falls. US
Shahid, Mahum; University of South Dakota. Sanford School of Medicine. Sioux Falls. US
Abdullah, Hafez Mohammad; University of South Dakota. Sanford School of Medicine. Sioux Falls. US
Bleeker, Jonathan; University of South Dakota. Sanford School of Medicine. Sioux Falls. US

Hematol., Transfus. Cell Ther. (Impr.) ; 43(3): 364-367, July-Sept. 2021. tab, ilus

Article in English | LILACS | ID: biblio-1346254

Subject(s)

Humans; Male; Female; Adult; Complement C3; Atypical Hemolytic Uremic Syndrome/drug therapy; Antibodies, Monoclonal

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Complement C3 / Atypical Hemolytic Uremic Syndrome Limits: Adult / Female / Humans / Male Language: English Journal: Hematol., Transfus. Cell Ther. (Impr.) Journal subject: Hematologia / TransfusÆo de Sangue Year: 2021 Type: Article Affiliation country: United States Institution/Affiliation country: University of South Dakota/US

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google